Clinical Trial

Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma

Study acronym: RUBIKID
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a pilot prospective longitudinal monocentric, non-comparative, nonrandomised, and non-controlled open study. is to test whether the intensity of 82-Rb uptake on PET acquisitions is associated to the aggressiveness of RCC on histology (ISUP grades), i.e., to successfully identify high-grade (ISUP grades 3 and 4) vs. lowgrade (ISUP grades 1 and 2) RCC.
Trial Details
NCT Number NCT07346404
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: Naogen Pharma
Conditions Renal Cell Carcinoma
Enrollment 50 participants
Start Date 2026-01-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-16